Skip to main content

and
  1. No Access

    Article

    Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

    The only current curative treatment for chronic lymphocytic leukemia (CLL) is allogenic hematopoietic stem cell transplantation. Chimeric antigen receptor treatment targeting CD19 for CLL achieved some complet...

    Damian Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon in Leukemia (2021)

  2. Article

    Open Access

    Sub-lethal ionizing radiation alters Foxp3 expression in CD4+ T regulatory (Treg) cells in vitro and in vivo

    Anita Kumari, Samantha Simon, Charlie Garnett-Benson in Journal for ImmunoTherapy of Cancer (2015)